109 related articles for article (PubMed ID: 1685330)
1. Influence of endogenous Thy1.1 cells upon the efficacy of an anti-Thy1.1 antibody-diphtheria toxin conjugate.
Yan B; Baker PD; Evans CH; Marsh JW
Bioconjug Chem; 1991; 2(4):207-10. PubMed ID: 1685330
[TBL] [Abstract][Full Text] [Related]
2. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
Ramakrishnan S; Houston LL
Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
[TBL] [Abstract][Full Text] [Related]
3. Antibody-mediated routing of diphtheria toxin in murine cells results in a highly efficacious immunotoxin.
Marsh JW
J Biol Chem; 1988 Nov; 263(31):15993-9. PubMed ID: 3263366
[TBL] [Abstract][Full Text] [Related]
4. Treatment of lymphoma with radiolabeled antibody: elimination of tumor cells lacking target antigen.
Nourigat C; Badger CC; Bernstein ID
J Natl Cancer Inst; 1990 Jan; 82(1):47-50. PubMed ID: 1967149
[TBL] [Abstract][Full Text] [Related]
5. Mutations in diphtheria toxin separate binding from entry and amplify immunotoxin selectivity.
Greenfield L; Johnson VG; Youle RJ
Science; 1987 Oct; 238(4826):536-9. PubMed ID: 3498987
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: antitumor effects, in vivo fate, and tumor cell mutants.
Thorpe PE; Blakey DC; Brown AN; Knowles PP; Knyba RE; Wallace PM; Watson GJ; Wawrzynczak EJ
J Natl Cancer Inst; 1987 Nov; 79(5):1101-12. PubMed ID: 2890786
[TBL] [Abstract][Full Text] [Related]
7. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
[TBL] [Abstract][Full Text] [Related]
8. Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen.
Youle RJ; Uckun FM; Vallera DA; Colombatti M
J Immunol; 1986 Jan; 136(1):93-8. PubMed ID: 3079613
[TBL] [Abstract][Full Text] [Related]
9. A flexible peptide spacer increases the efficacy of holoricin anti-T cell immunotoxins.
Marsh JW; Neville DM
J Immunol; 1988 May; 140(10):3674-8. PubMed ID: 2896212
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of immunotoxin efficacy by acid-cleavable cross-linking agents utilizing diphtheria toxin and toxin mutants.
Neville DM; Srinivasachar K; Stone R; Scharff J
J Biol Chem; 1989 Sep; 264(25):14653-61. PubMed ID: 2475487
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the galactose-binding sites of ricin by its linkage to antibody. Specific cytotoxic effects of the conjugates.
Thorpe PE; Ross WC; Brown AN; Myers CD; Cumber AJ; Foxwell BM; Forrester JT
Eur J Biochem; 1984 Apr; 140(1):63-71. PubMed ID: 6608447
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic activities of recombinant immunotoxins composed of Pseudomonas toxin or diphtheria toxin toward lymphocytes from patients with adult T-cell leukemia.
Kreitman RJ; Chaudhary VK; Waldmann TA; Hanchard B; Cranston B; FitzGerald DJ; Pastan I
Leukemia; 1993 Apr; 7(4):553-62. PubMed ID: 8464234
[TBL] [Abstract][Full Text] [Related]
13. Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen.
Badger CC; Bernstein ID
J Exp Med; 1983 Mar; 157(3):828-42. PubMed ID: 6403649
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity acquired by conjugation of an anti-Thy1.1 monoclonal antibody and the ribosome-inactivating protein, gelonin.
Thorpe PE; Brown AN; Ross WC; Cumber AJ; Detre SI; Edwards DC; Davies AJ; Stirpe F
Eur J Biochem; 1981 Jun; 116(3):447-54. PubMed ID: 6790277
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody therapy of spontaneous AKR T-cell leukemia.
Badger CC; Shulman H; Peterson AV; Bernstein ID
Cancer Res; 1986 Aug; 46(8):4058-63. PubMed ID: 2873885
[TBL] [Abstract][Full Text] [Related]
16. Efficient transplantation of human non-T-leukemia cells into nude mice and induction of complete regression of the transplanted distinct tumors by ricin A-chain conjugates of monoclonal antibodies SN5 and SN6.
Hara H; Luo Y; Haruta Y; Seon BK
Cancer Res; 1988 Aug; 48(16):4673-80. PubMed ID: 2969282
[TBL] [Abstract][Full Text] [Related]
17. Increased toxicity of diphtheria toxin for human lymphoblastoid cells following covalent linkage to anti-(human lymphocyte) globulin or its F(ab')2 fragment.
Ross WC; Thorpe PE; Cumber AJ; Edwards DC; Hinson CA; Davies AJ
Eur J Biochem; 1980 Mar; 104(2):381-90. PubMed ID: 6965909
[TBL] [Abstract][Full Text] [Related]
18. T-cell depletion and graft survival induced by anti-human CD3 immunotoxins in human CD3epsilon transgenic mice.
Weetall M; Digan ME; Hugo R; Mathew S; Hopf C; Tart-Risher N; Zhang J; Shi V; Fu F; Hammond-McKibben D; West S; Brack R; Brinkmann V; Bergman R; Neville D; Lake P
Transplantation; 2002 May; 73(10):1658-66. PubMed ID: 12042656
[TBL] [Abstract][Full Text] [Related]
19. Effective targeted cytotoxicity of neuroblastoma cells.
Thomas PB; Delatte SJ; Sutphin A; Frankel AE; Tagge EP
J Pediatr Surg; 2002 Mar; 37(3):539-44. PubMed ID: 11877684
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of target cells to immunotoxins: possible role of cell-surface antigens.
Colombatti M; Bron C
Immunology; 1985 Jun; 55(2):331-8. PubMed ID: 2861156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
